Pacing for neurally mediated syncope: is placebo powerless?

Abstract

BACKGROUND After two recent controlled trials failed to prove superiority of cardiac pacing over placebo in patients affected by neurally mediated syncope, a widely accepted opinion is that cardiac pacing therapy is not very effective and that a strong placebo effect exists. AIM To measure the effect of placebo pacing therapy. METHOD AND RESULTS We compared the recurrence rate of syncope during placebo vs. no treatment in controlled trials of drug or pacing therapy. Syncope recurred in 38% of 252 patients randomized to placebo pooled from five trials vs. 34% of 881 patients randomized to no treatment pooled from eight trials. The corresponding recurrence rate with active cardiac pacing was 15% in 203 patients from six trials. CONCLUSIONS Placebo is not an effective therapy for neurally mediated syncope. Different selection criteria in patients who are candidates for cardiac pacing-for example, presence, absence, or severity of the cardioinhibitory reflex may separate positive from negative trials.

Statistics

0500100015002008200920102011201220132014201520162017
Citations per Year

1,369 Citations

Semantic Scholar estimates that this publication has 1,369 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Brignole2007PacingFN, title={Pacing for neurally mediated syncope: is placebo powerless?}, author={M Brignole and Richard N. Sutton}, journal={Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology}, year={2007}, volume={9 1}, pages={31-3} }